ロード中...
Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer
PURPOSE: Gene expression profiling assays are frequently used to guide adjuvant chemotherapy decisions in hormone receptor–positive, lymph node–negative breast cancer. We hypothesized that the clinical value of these new tools would be more fully realized when appropriately integrated with high-qual...
保存先:
出版年: | J Clin Oncol |
---|---|
主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
American Society of Clinical Oncology
2016
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5455310/ https://ncbi.nlm.nih.gov/pubmed/27998227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.67.7195 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|